Moreover, individual factors associated with MetS have been associated with different mechanisms in insulin resistance, aromatase activity, adipokine secretion, angiogenesis, high CRP levels, glucose use, and oxidative stress and its consequent DNA impairment, which together may enhance cancer risk [70]. Here, CYP19A1 is linked to metabolic syndrome.